Psychopharmacol Bull. 1991;27(3):217-24.

To increase power in randomized clinical trials without increasing sample size.

Source

Department of Psychiatry and Behavioral Sciences, Stanford University, CA 94305.

Abstract

The power of a randomized clinical trial (RCT) depends on two factors: sample size and effect size. Most psychiatric research design strategies focus on increasing sample size, despite major problems in recruiting large numbers of subjects or funding such costly studies. It is possible to increase power in RCTs in a variety of ways without increasing sample size, in essence by increasing effect size by decreasing within-group variance. Such strategies are presented and discussed.

PMID:: 1775591; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

MH-30854/MH/NIMH NIH HHS/United States

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings. [J Clin Oncol. 2007]
Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL, Krzyzanowska MK, Pintilie M, Tannock IF. J Clin Oncol. 2007 Aug 10; 25(23):3482-7.
Review Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. [Health Technol Assess. 2001]
Review Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Health Technol Assess. 2001; 5(33):1-56.
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment? [Crit Care Med. 2009]
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?
Roozenbeek B, Maas AI, Lingsma HF, Butcher I, Lu J, Marmarou A, McHugh GS, Weir J, Murray GD, Steyerberg EW, et al. Crit Care Med. 2009 Oct; 37(10):2683-90.
A three-stage clinical trial design for rare disorders. [Stat Med. 2001]
A three-stage clinical trial design for rare disorders.
Honkanen VE, Siegel AF, Szalai JP, Berger V, Feldman BM, Siegel JN. Stat Med. 2001 Oct 30; 20(20):3009-21.
Review Implications of clinical trial design on sample size requirements. [Schizophr Bull. 2008]
Review Implications of clinical trial design on sample size requirements.
Leon AC. Schizophr Bull. 2008 Jul; 34(4):664-9. Epub 2008 May 9.

See reviews... See all...

Cited by 5 PubMed Central articles

Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents. [J Consult Clin Psychol. 2009]
Sources of site differences in the efficacy of a multisite clinical trial: the Treatment of SSRI-Resistant Depression in Adolescents.
Spirito A, Abebe KZ, Iyengar S, Brent D, Vitiello B, Clarke G, Wagner KD, Asarnow J, Emslie G, Keller M. J Consult Clin Psychol. 2009 Jun; 77(3):439-50.
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? [Schizophr Bull. 2010]
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Dubé S, Ereshefsky L, Gharabawi G, et al. Schizophr Bull. 2010 May; 36(3):504-9. Epub 2008 Aug 22.
Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristics. [Contemp Clin Trials. 2008]
Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristics.
Robinson TN, Kraemer HC, Matheson DM, Obarzanek E, Wilson DM, Haskell WL, Pruitt LA, Thompson NS, Haydel KF, Fujimoto M, et al. Contemp Clin Trials. 2008 Jan; 29(1):56-69. Epub 2007 May 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

To increase power in randomized clinical trials without increasing sample size.
To increase power in randomized clinical trials without increasing sample size.
Psychopharmacol Bull. 1991 ;27(3):217-24.

PubMed
Can science survive in the modern age?
Can science survive in the modern age?
Science. 1971 Oct 1 ;174(4004):21-30.

PubMed
Iodopsin, a red-sensitive cone visual pigment in the chicken retina.
Iodopsin, a red-sensitive cone visual pigment in the chicken retina.
Photochem Photobiol. 1991 Dec ;54(6):1061-70.

PubMed
Effects of cholinergic-rich neural grafts on radial maze performance of rats aft...
Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basal forebrain.
Neuroscience. 1991 ;45(3):587-607.

PubMed
Genetic hybrids of Plasmodium falciparum identified by amplification of genomic ...
Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts.
Mol Biochem Parasitol. 1991 Dec ;49(2):239-43.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: